The portfolio of venture capital firm Foresite Capital has several such drugs, the product of regular trips it has made ... like GIP. [Eli Lilly’s] Mounjaro is a next-generation drug.

The White River High boys will head to the state wrestling championships on a serious high note, having won last week’s district title and qualified a whopping 15 wrestlers to the Class 3A state meet.

Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...

Ore Huiying / Bloomberg / Getty Images Pharmaceutical company Eli Lilly is expected to report fourth-quarter earnings before the bell Thursday. Analysts tracking the company see increased sales ...

Getty Images Pharmaceutical company Eli Lilly is expected to report fourth-quarter earnings before the bell Thursday. Analysts tracking the company see increased sales and profit for Eli Lilly in ...

Eli Lilly (NYSE:LLY) is setting the stage for a strong 2025, with its fourth-quarter results and forward guidance reflecting solid momentum. The company's adjusted earnings per share are expected ...

Thanks to impressive sales growth across multiple therapeutic areas in 2024, Eli Lilly seems to ... that’s defined the field of late, admitting that Lilly “fell short” of meeting its own ...

Eli Lilly exceeded analyst forecasts for both sales and earnings in Q4 2024. As has been true for a while, sales of GLP-1 drugs Mounjaro and Zepbound drove both sales and earnings growth.

Mike Czapar-- Senior Vice President, Investor Relations Good morning. Thank you for joining us for Eli Lilly and Company's Q4 2024 earnings call. I'm Mike Czapar, senior vice president of investor ...